Clamoxyl Ready-To-Use
Active substance
ATC code
Species
Dogs, cats, sheep, pigs and cattle
Indications
For the treatment of infections caused by susceptible organisms in dogs, cats, sheep, pigs and cattle. The product is not effective against betalactamase producing organisms.
Dose to be administered and administration route
The recommended dosage rate is 7 mg/kg bodyweight once daily for up to 5 days by subcutaneous (dogs, cats), or intramuscular (dogs, cats, sheep, pigs and cattle) injection.
If the volume to be given is greater than 15 ml (cattle) and 5 ml (sheep and pigs) the dose should be divided and the remaining should be injected in another site.
Shake the vial well to suspend the active ingredient before use.
Swab rubber septum and remove required volume aseptically.
Do not breach more than 40 times.
Massage the injection site after administration. Use a new anatomical site for repeated injections. To ensure the correct dosage, bodyweight should be determined as accurately as possible to avoid overdosing.
In common with other penicillin preparations hydrolysis takes place rapidly in the presence of water. It is important therefore that a dry syringe is used when extracting the suspension for injection to avoid contaminating the remaining contents of the vial with drops of water.
Adverse reactions
Use of the product may occasionally result in local tissue reaction.
Penicillins and cephalosporins may cause hypersensitivity (allergy, allergic skin reactions) after use. Allergic reactions may occasionally be serious (anaphylaxis).
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Dispensing
POM-V - Prescription Only Medicine – VeterinarianSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Clamoxyl Ready-To-Use 150 mg/ml suspension for injection
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance |
mg/ml |
Amoxicillin |
150 |
(As Amoxicillin trihydrate)
For a full list of excipients please see section 6.1
3. PHARMACEUTICAL FORM
Suspension for injection
A white to off white oily suspension
4. CLINICAL PARTICULARS
4.1 Target species
Dogs, cats, sheep, pigs and cattle
4.2 Indications for use, specifying the target species
For the treatment of infections caused by susceptible organisms in dogs, cats, sheep, pigs and cattle. The product is not effective against betalactamase producing organisms.
4.3 Contraindications
Not to be used in rabbits, guinea pigs, hamsters or gerbils. The suspension is not suitable for intravenous or intrathecal administration.
4.4 Special warnings for each target species
The product is not effective against beta-lactamase producing organisms. Complete cross-resistance has been shown between amoxicillin and other penicillins, in particular amino-penicillins.
Use of the product/amoxicillin should be carefully considered when antimicrobial susceptibility testing has shown resistance to penicillins because its effectiveness may be reduced.
4.5 Special precautions for use
i) Special precautions for use in animals
Do not use in animals with known sensitivity to the active substance.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local epidemiological information. This product does not contain an antimicrobial preservative.
ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals
Care should be taken to avoid accidental self injection.
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reaction to these substances may occasionally be serious.
Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations. Handle this product with great care to avoid exposure taking all recommended precautions.
If you develop symptoms following exposure, such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing, are more serious symptoms and require urgent medical attention. Wash hands after use.
4.6 Adverse reactions (frequency and seriousness)
Use of the product may occasionally result in local tissue reaction.
Penicillins and cephalosporins may cause hypersensitivity (allergy, allergic skin reactions) after use. Allergic reactions may occasionally be serious (anaphylaxis).
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
4.7 Use during pregnancy, lactation or lay
None
4.8 Interaction with other medicinal products and other forms of interaction
It is not generally recommended to use bactericidal and bacteriostatic antibiotics at the same time.
Beta-lactam antibiotics are known to interact with antibiotics with bacteriostatic action such as chloramphenicol, macrolides, sulfonamides and tetracyclines. There is also synergic action of penicillins with aminoglycosides.
4.9 Amounts to be administered and administration route
The recommended dosage rate is 7 mg/kg bodyweight once daily for up to 5 days by subcutaneous (dogs, cats), or intramuscular (dogs, cats, sheep, pigs and cattle) injection.
If the volume to be given is greater than 15 ml (cattle) and 5 ml (sheep and pigs) the dose should be divided and the remaining should be injected in another site.
Shake the vial well to suspend the active ingredient before use.
Swab rubber septum and remove required volume aseptically.
Do not breach more than 40 times.
Massage the injection site after administration. Use a new anatomical site for repeated injections. To ensure the correct dosage, bodyweight should be determined as accurately as possible to avoid overdosing.
In common with other penicillin preparations hydrolysis takes place rapidly in the presence of water. It is important therefore that a dry syringe is used when extracting the suspension for injection to avoid contaminating the remaining contents of the vial with drops of water.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Amoxicillin is of a very low order of acute toxicity and is well tolerated by the parenteral route. Occasional injection site reactions may occur with the recommended dose, but no other adverse side effects are to be expected from accidental overdosing.
4.11 Withdrawal periods
Meat and offal: Cattle: 54 days
Sheep: 47 days Pigs: 47 days
Milk: Cattle: 60 hours from the last treatment.
Not to be used in sheep producing milk for human consumption.
5. PHARMACOLOGICAL PROPERTIES
ATCVet Code: QJ01CA04
Amoxicillin is a broad-spectrum semi-synthetic penicillin which is bactericidal in vitro against a wide range of Gram-positive and Gramnegative bacteria including the following: Actinomyces spp., Bacillus spp., Bordetella bronchiseptica, Clostridium spp., Corynebacterium spp, Escherichia coli, Fusobacterium spp., Haemophilus spp., Leptospira spp., Moraxella spp., Pasteurella spp., Proteus spp., Salmonella spp., Streptococci, Staphylococci (penicillin-sensitive strains).
The product is indicated for the treatment of infections caused by Amoxicillin-sensitive organisms in dogs, cats, sheep, pigs and cattle.
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Polysorbate 80
Aluminium Stearate
Ethyl Oleate
6.2 Incompatibilities
None known
6.3 Shelf-life
Shelf life of the veterinary medicinal product as packaged for sale: 3 years. Shelf life after first opening the immediate packaging: 28 days.
6.4 Special precautions for storage
Do not store above 25°C.
Following withdrawal of the first dose, use the product within 28 days. Discard unused material.
6.5 Nature and composition of immediate packaging
Carton containing 6 100ml clear colourless type III glass vials with chlorobutyl bungs with an aluminium overseal.
Carton containing 4 250ml clear colourless type II or type III glass vials with chlorobutyl bungs with an aluminium overseal.
Not all pack sizes may be marketed.
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
Zoetis UK Limited
1st Floor, Birchwood Building
Springfield Drive
Leatherhead
Surrey
KT22 7LP
8. MARKETING AUTHORISATION NUMBER
Vm 42058/4016
9. DATE OF THE FIRST AUTHORISATION
03 December 1990
10. DATE OF REVISION OF THE TEXT
April 2022
Approved: 08 April 2022